gastroesophageal cancer
Showing 1 - 25 of >10,000
Gastro-Esophageal Cancer Trial in Copenhagen
Not yet recruiting
- Gastro-Esophageal Cancer
-
Copenhagen, DenmarkRigshospitalet
Nov 17, 2023
Gastric or Gastroesophageal Cancer Trial in Kawasaki-shi, Chuo-ku (FPA144)
Completed
- Gastric or Gastroesophageal Cancer
-
Kawasaki-shi, Kanagawa, Japan
- +1 more
Jun 13, 2023
GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)
Recruiting
- GastroEsophageal Cancer
- Gastric Cancer
- Neratinib
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Oct 25, 2023
Neoadjuvant Therapy in Gastric and Gastroesophageal Cancer
Completed
- Patients With Locally Advanced Carcinoma of the Stomach and Oesophagogastric Junction
- CT scan
- (no location specified)
Sep 13, 2023
Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)
Recruiting
- Gastric Cancer
- +10 more
- Docetaxel
- +3 more
-
Kyiv, UkraineNational Cancer Institute
Aug 31, 2023
Gastro-esophageal Cancer Trial (Resistance training, Protein supplement)
Not yet recruiting
- Gastro-esophageal Cancer
- Resistance training
- Protein supplement
- (no location specified)
Dec 15, 2022
Esophagus Cancer, Adenocarcinoma Trial (BioXmark™)
Recruiting
- Esophagus Cancer, Adenocarcinoma
- BioXmark™
-
Copenhagen, DenmarkRigshopitalet, Department of Surgery and Transplantation
Nov 7, 2022
GastroEsophageal Cancer Trial in Tampa (Fitbit Data Collection, Nutrition Counseling, Survey)
Recruiting
- GastroEsophageal Cancer
- Fitbit Data Collection
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jun 29, 2022
GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)
Not yet recruiting
- GastroEsophageal Cancer
-
Lyon, FranceCentre Léon Bérard
Dec 1, 2022
Nivolumab in Treatment of Early Stage Esophageal or
Not yet recruiting
- Esophageal Carcinoma
- Gastroesophageal Junction Carcinoma
-
Louisville, Kentucky
- +2 more
Mar 21, 2023
GastroEsophageal Cancer, Gastric Cancer Trial in New York (Lenvatinib, Pembrolizumab)
Recruiting
- GastroEsophageal Cancer
- Gastric Cancer
-
New York, New York
- +1 more
Aug 12, 2022
Gastric Cancer, GastroEsophageal Cancer, Fruquintinib Trial in Nanning (Fruquintinib + SOX)
Recruiting
- Gastric Cancer
- +3 more
- Fruquintinib + SOX
-
Nanning, ChinaGuangxi Medical University Cancer Hospital
Dec 2, 2022
Within Postoperative Wound-Healing Microenvironment in
Recruiting
- GastroEsophageal Cancer
- prospective collection of surgical exudates (SEs)
-
Fairfax, VirginiaInova Schar Cancer Institute
Jul 29, 2022
Gastric and Pancreatic Cancers in Latin America
Not yet recruiting
- Gastric Cancer
- +2 more
- Observational study
- (no location specified)
Jun 20, 2023
Resectable Esophageal Cancer, GastroEsophageal Cancer Trial in Madison (combination product, drug, radiation)
Active, not recruiting
- Resectable Esophageal Cancer
- GastroEsophageal Cancer
- Avelumab combined with Chemoradiation
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 28, 2022
Gastric Cancer Trial in Beijing (S-1, Trastuzumab, Oxaliplatin)
Completed
- Gastric Cancer
- S-1
- +3 more
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences
Aug 14, 2022
GastroEsophageal Cancer, Incurable Disease Trial in Amsterdam, Utrecht (Exercise intervention, Nutrition intervention)
Active, not recruiting
- GastroEsophageal Cancer
- Incurable Disease
- Exercise intervention
- Nutrition intervention
-
Amsterdam, Noord-Holland, Netherlands
- +1 more
Nov 16, 2023
Gastro-Intestinal Cancer Trial in New Brunswick (Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI))
Recruiting
- Gastro-Intestinal Cancer
- Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI)
-
Hamilton, New Jersey
- +6 more
Oct 24, 2022
Stent Migration, GastroEsophageal Cancer Trial in Paris (Gastroesophageal stent placement)
Not yet recruiting
- Stent Migration
- GastroEsophageal Cancer
- Gastroesophageal stent placement
-
Paris, FranceFrench Society of Digestive Endoscopy
Jun 23, 2022
Colorectal Cancer, Gastroesophageal Cancer, Ovarian Cancer Trial (IVX037)
Not yet recruiting
- Colorectal Cancer
- +2 more
- IVX037
- (no location specified)
Jun 21, 2022
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,
Recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +23 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 5, 2022
Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange (Cabozantinib, Pembrolizumab)
Recruiting
- Gastric Adenocarcinoma
- GastroEsophageal Cancer
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Apr 4, 2022
GastroEsophageal Cancer Trial in Boston (Irinotecan, Oxaliplatin, Leucovorin)
Active, not recruiting
- GastroEsophageal Cancer
- Irinotecan
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 7, 2022
Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)
Not yet recruiting
- Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
- XELOX combined with Fruquintinib and Sintilimab
- (no location specified)
Oct 17, 2023
Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,
Recruiting
- Gastric Cancer
- GastroEsophageal Cancer
- Pembrolizumab
- +2 more
-
Aurora, Colorado
- +2 more
Jan 4, 2023